# Nautilus Biotechnology, Inc. — Form D

Nautilus Biotechnology, Inc. of San Carlos, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-04-22. The offering totals $50.4M. Industry: Other.

## Offering

- Filed: 2020-04-22
- Form: D
- Accession: 0001741638-20-000002
- Industry: Other
- Exemptions: 06b
- Total offering: $50.4M
- Remaining: $50.4M
- Investors: 14
- Date of first sale: 2020-04-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-365575

## Issuer

- Name: Nautilus Biotechnology, Inc.
- CIK: 0001741638
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 201 Industrial Rd, STE 310, San Carlos, CA, 94070
- Phone: (206) 333-2001

## Officers, directors & promoters (7)

| Name | Role | Location |
| --- | --- | --- |
| Matthew Posard | Director | Waltham, MA |
| Stuart Nagae | Director | Seattle, WA |
| Vijay Pande | Director | Richmond, CA |
| Farzad Nazem | Director | Seattle, WA |
| Sujal Patel | Director | Seattle, WA |
| Sujal Patel | Executive Officer | Seattle, WA |
| Parag Mallick | Director | Seattle, WA |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2020-05-28](https://search.stillhousedata.com/formd/0001741638-20-000003) | D/A | $76.1M | $76.1M |
| [2018-05-30](https://search.stillhousedata.com/formd/0001741638-18-000001) | D | $27.2M | $27.2M |

## More

- [CIK 1741638 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1741638&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001741638-20-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.